Public Eye calls on Swiss Federal Council to use compulsory licensing against exorbitant drug prices
Public Eye "Problems with access to lifesaving drugs no longer only affect developing and emerging countries. Even the Swiss healthcare system is struggling to cope with the price explosion of new treatments, in particular cancer drugs. But the Federal Council has the means to act: by resorting to a compulsory licence, it can allow cheaper generic drugs to be marketed despite the existence of a patent.
With the support of the Swiss Cancer League, Public Eye is calling on Federal Councillors Berset and Schneider-Ammann to take domestic and foreign policy measures to guarantee affordable drugs and to use compulsory licences whenever necessary." (Photo: Arzneimittelpreise/Techniker Krankenkasse/flickr, CC BY-NC-ND 2.0)